These showed the same pattern of inverse associations for ER + PR + subtypes as for overall breast cancer; for the other subtypes the associations were often inverse but there was more variability, with statistically significant heterogeneity for age and oral contraceptive use in the ER + PR– subtype. This evidence concerns the gene PGR and breast carcinoma.